186 related articles for article (PubMed ID: 30055578)
1. Pancreatic adenocarcinoma: insights into patterns of recurrence and disease behavior.
Sahin IH; Elias H; Chou JF; Capanu M; O'Reilly EM
BMC Cancer; 2018 Jul; 18(1):769. PubMed ID: 30055578
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: A Surveillance Epidemiology and End Results database analysis.
Oweira H; Petrausch U; Helbling D; Schmidt J; Mannhart M; Mehrabi A; Schöb O; Giryes A; Decker M; Abdel-Rahman O
World J Gastroenterol; 2017 Mar; 23(10):1872-1880. PubMed ID: 28348494
[TBL] [Abstract][Full Text] [Related]
3. The indolent nature of pulmonary metastases from ductal adenocarcinoma of the pancreas.
Downs-Canner S; Zenati M; Boone BA; Varley PR; Steve J; Hogg ME; Zureikat A; Zeh HJ; Lee KK
J Surg Oncol; 2015 Jul; 112(1):80-5. PubMed ID: 26153355
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics of initial recurrence in lung after surgical resection for pancreatic ductal adenocarcinoma.
Otsuka H; Uemura K; Kondo N; Sumiyoshi T; Nakagawa N; Okada K; Seo S; Murakami Y; Takahashi S
Pancreatology; 2020 Oct; 20(7):1472-1478. PubMed ID: 32900632
[TBL] [Abstract][Full Text] [Related]
5. Peripancreatic fat invasion is an independent predictor of poor outcome following pancreaticoduodenectomy for pancreatic ductal adenocarcinoma.
Jamieson NB; Foulis AK; Oien KA; Dickson EJ; Imrie CW; Carter R; McKay CJ
J Gastrointest Surg; 2011 Mar; 15(3):512-24. PubMed ID: 21116727
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of metastatic pancreatic adenocarcinoma: Lung metastasis show better prognosis than liver metastasis-a case control study.
Decoster C; Gilabert M; Autret A; Turrini O; Oziel-Taieb S; Poizat F; Giovannini M; Viens P; Iovanna J; Raoul JL
Oncotarget; 2016 Jul; 7(29):45649-45655. PubMed ID: 27286454
[TBL] [Abstract][Full Text] [Related]
7. Association between primary origin (head, body and tail) of metastasised pancreatic ductal adenocarcinoma and oncologic outcome: A population-based analysis.
Mackay TM; van Erning FN; van der Geest LGM; de Groot JWB; Haj Mohammad N; Lemmens VE; van Laarhoven HW; Besselink MG; Wilmink JW;
Eur J Cancer; 2019 Jan; 106():99-105. PubMed ID: 30476732
[TBL] [Abstract][Full Text] [Related]
8. Different clinical presentations of metachronous pulmonary metastases after resection of pancreatic ductal adenocarcinoma: Retrospective study and review of the literature.
Lovecek M; Skalicky P; Chudacek J; Szkorupa M; Svebisova H; Lemstrova R; Ehrmann J; Melichar B; Yogeswara T; Klos D; Vrba R; Havlik R; Mohelnikova-Duchonova B
World J Gastroenterol; 2017 Sep; 23(35):6420-6428. PubMed ID: 29085191
[TBL] [Abstract][Full Text] [Related]
9. Oligometastatic pulmonary metastasis in pancreatic cancer patients: Safety and outcome of resection.
Ilmer M; Schiergens TS; Renz BW; Schneider C; Sargut M; Waligora R; Weniger M; Hartwig W; Ceyhan GO; Friess H; Werner J; D'Haese JG
Surg Oncol; 2019 Dec; 31():16-21. PubMed ID: 31473583
[TBL] [Abstract][Full Text] [Related]
10. Resection of pancreatic ductal adenocarcinoma with synchronous distant metastasis: is it worthwhile?
Buc E; Orry D; Antomarchi O; Gagnière J; Da Ines D; Pezet D
World J Surg Oncol; 2014 Nov; 12():347. PubMed ID: 25407113
[TBL] [Abstract][Full Text] [Related]
11. Survival Impact of Pulmonary Metastasis as Recurrence of Pancreatic Ductal Adenocarcinoma.
Yamashita K; Miyamoto A; Hama N; Asaoka T; Maeda S; Omiya H; Takami K; Doki Y; Mori M; Nakamori S
Dig Surg; 2015; 32(6):464-71. PubMed ID: 26517228
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic adenocarcinoma in a young patient population--12-year experience at Memorial Sloan Kettering Cancer Center.
Duffy A; Capanu M; Allen P; Kurtz R; Olson SH; Ludwig E; Klimstra DS; O'Reilly EM
J Surg Oncol; 2009 Jul; 100(1):8-12. PubMed ID: 19384918
[TBL] [Abstract][Full Text] [Related]
13. Para-aortic node involvement is not an independent predictor of survival after resection for pancreatic cancer.
Sperti C; Gruppo M; Blandamura S; Valmasoni M; Pozza G; Passuello N; Beltrame V; Moletta L
World J Gastroenterol; 2017 Jun; 23(24):4399-4406. PubMed ID: 28706422
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases.
Serrano PE; Gu CS; Husien M; Jalink D; Ritter A; Martel G; Tsang ME; Law CH; Hallet J; McAlister V; Sela N; Solomon H; Moulton CA; Gallinger S; Levine M
J Surg Oncol; 2019 Dec; 120(8):1420-1426. PubMed ID: 31612509
[TBL] [Abstract][Full Text] [Related]
15. Preoperative evaluation of pancreatic ductal adenocarcinoma with synchronous liver metastasis: Diagnosis and assessment of unresectability.
Shi HJ; Jin C; Fu DL
World J Gastroenterol; 2016 Dec; 22(45):10024-10037. PubMed ID: 28018110
[TBL] [Abstract][Full Text] [Related]
16. Impact of Portal Vein Involvement from Pancreatic Cancer on Metastatic Pattern After Surgical Resection.
Mierke F; Hempel S; Distler M; Aust DE; Saeger HD; Weitz J; Welsch T
Ann Surg Oncol; 2016 Dec; 23(Suppl 5):730-736. PubMed ID: 27554501
[TBL] [Abstract][Full Text] [Related]
17. Resected pancreatic ductal adenocarcinomas with recurrence limited in lung have a significantly better prognosis than those with other recurrence patterns.
Wangjam T; Zhang Z; Zhou XC; Lyer L; Faisal F; Soares KC; Fishman E; Hruban RH; Herman JM; Laheru D; Weiss M; Li M; De Jesus-Acosta A; Wolfgang CL; Zheng L
Oncotarget; 2015 Nov; 6(34):36903-10. PubMed ID: 26372811
[TBL] [Abstract][Full Text] [Related]
18. Preoperative risk factors for early recurrence in patients with resectable pancreatic ductal adenocarcinoma after curative intent surgical resection.
Kim NH; Kim HJ
Hepatobiliary Pancreat Dis Int; 2018 Oct; 17(5):450-455. PubMed ID: 30237091
[TBL] [Abstract][Full Text] [Related]
19. Pancreatic resection for M1 pancreatic ductal adenocarcinoma.
Shrikhande SV; Kleeff J; Reiser C; Weitz J; Hinz U; Esposito I; Schmidt J; Friess H; Büchler MW
Ann Surg Oncol; 2007 Jan; 14(1):118-27. PubMed ID: 17066229
[TBL] [Abstract][Full Text] [Related]
20. Overall survival of patients with recurrent pancreatic cancer treated with systemic therapy: a retrospective study.
Gbolahan OB; Tong Y; Sehdev A; O'Neil B; Shahda S
BMC Cancer; 2019 May; 19(1):468. PubMed ID: 31101022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
